Sapiens International Corporation N.V.

Informe acción NasdaqGS:SPNS

Capitalización de mercado: US$1.7b

Sapiens International Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Sapiens International ha aumentado sus beneficios a una tasa media anual de 24%, mientras que los beneficios de la industria de Software han experimentado un crecimiento de 14.9% anual. Los ingresos han ido creciendo a una tasa media de 11.9% al año. La rentabilidad financiera de Sapiens International es de 14%, y sus márgenes netos son de 12.1%.

Información clave

24.0%

Tasa de crecimiento de los beneficios

21.7%

Tasa de crecimiento del BPA

Crecimiento de la industria Software 17.3%
Tasa de crecimiento de los ingresos11.9%
Rentabilidad financiera14.0%
Margen neto12.1%
Próxima actualización de resultados08 May 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Is Now An Opportune Moment To Examine Sapiens International Corporation N.V. (NASDAQ:SPNS)?

Apr 26
Is Now An Opportune Moment To Examine Sapiens International Corporation N.V. (NASDAQ:SPNS)?

Sapiens: Accelerating In Q4 With Margin Levers Pulled

Apr 16

Investors Appear Satisfied With Sapiens International Corporation N.V.'s (NASDAQ:SPNS) Prospects

Apr 11
Investors Appear Satisfied With Sapiens International Corporation N.V.'s (NASDAQ:SPNS) Prospects

Estimating The Fair Value Of Sapiens International Corporation N.V. (NASDAQ:SPNS)

Mar 25
Estimating The Fair Value Of Sapiens International Corporation N.V. (NASDAQ:SPNS)

Returns Are Gaining Momentum At Sapiens International (NASDAQ:SPNS)

Feb 21
Returns Are Gaining Momentum At Sapiens International (NASDAQ:SPNS)

Sapiens: Double-Lever Margin Lift

Feb 07

Sapiens International (NASDAQ:SPNS) Has A Rock Solid Balance Sheet

Feb 05
Sapiens International (NASDAQ:SPNS) Has A Rock Solid Balance Sheet

Is It Time To Consider Buying Sapiens International Corporation N.V. (NASDAQ:SPNS)?

Jan 09
Is It Time To Consider Buying Sapiens International Corporation N.V. (NASDAQ:SPNS)?

Here's Why Sapiens International (NASDAQ:SPNS) Has Caught The Eye Of Investors

Dec 27
Here's Why Sapiens International (NASDAQ:SPNS) Has Caught The Eye Of Investors

These 4 Measures Indicate That Sapiens International (NASDAQ:SPNS) Is Using Debt Safely

Nov 06
These 4 Measures Indicate That Sapiens International (NASDAQ:SPNS) Is Using Debt Safely

Investors Will Want Sapiens International's (NASDAQ:SPNS) Growth In ROCE To Persist

Oct 10
Investors Will Want Sapiens International's (NASDAQ:SPNS) Growth In ROCE To Persist

Sapiens International Corporation N.V. (NASDAQ:SPNS) Shares Could Be 21% Above Their Intrinsic Value Estimate

Sep 15
Sapiens International Corporation N.V. (NASDAQ:SPNS) Shares Could Be 21% Above Their Intrinsic Value Estimate

Do Sapiens International's (NASDAQ:SPNS) Earnings Warrant Your Attention?

Aug 18
Do Sapiens International's (NASDAQ:SPNS) Earnings Warrant Your Attention?

Sapiens International (NASDAQ:SPNS) Could Easily Take On More Debt

Aug 03
Sapiens International (NASDAQ:SPNS) Could Easily Take On More Debt

Is It Too Late To Consider Buying Sapiens International Corporation N.V. (NASDAQ:SPNS)?

Jun 23
Is It Too Late To Consider Buying Sapiens International Corporation N.V. (NASDAQ:SPNS)?

Is Sapiens International (NASDAQ:SPNS) Using Too Much Debt?

May 05
Is Sapiens International (NASDAQ:SPNS) Using Too Much Debt?

Estimating The Fair Value Of Sapiens International Corporation N.V. (NASDAQ:SPNS)

Apr 21
Estimating The Fair Value Of Sapiens International Corporation N.V. (NASDAQ:SPNS)

When Should You Buy Sapiens International Corporation N.V. (NASDAQ:SPNS)?

Mar 13
When Should You Buy Sapiens International Corporation N.V. (NASDAQ:SPNS)?

Sapiens International (NASDAQ:SPNS) Has A Rock Solid Balance Sheet

Feb 03
Sapiens International (NASDAQ:SPNS) Has A Rock Solid Balance Sheet

Sapiens International (NASDAQ:SPNS) Is Looking To Continue Growing Its Returns On Capital

Dec 20
Sapiens International (NASDAQ:SPNS) Is Looking To Continue Growing Its Returns On Capital

Is There An Opportunity With Sapiens International Corporation N.V.'s (NASDAQ:SPNS) 23% Undervaluation?

Dec 07
Is There An Opportunity With Sapiens International Corporation N.V.'s (NASDAQ:SPNS) 23% Undervaluation?

Why Sapiens International Corporation N.V. (NASDAQ:SPNS) Could Be Worth Watching

Oct 11
Why Sapiens International Corporation N.V. (NASDAQ:SPNS) Could Be Worth Watching

Sapiens International Suffers From Growth Slowdown And Strong Dollar

Sep 28

Sapiens International's (NASDAQ:SPNS) Returns On Capital Are Heading Higher

Sep 20
Sapiens International's (NASDAQ:SPNS) Returns On Capital Are Heading Higher

Sapiens' ALE solution to reduce legacy system transformation costs by 50%

Sep 19

AEGIS selects Sapiens to automate and modernize its reinsurance processes

Sep 06

Sapiens goes ex-dividend tomorrow

Aug 15

Is Sapiens International (NASDAQ:SPNS) Using Too Much Debt?

Aug 04
Is Sapiens International (NASDAQ:SPNS) Using Too Much Debt?

Sapiens Non-GAAP EPS of $0.27 misses by $0.03, revenue of $118.6M misses by $4.65M

Aug 03

Sapiens Still Sees No Margin Pressure, Only Offshoring Benefits

Jul 24

When Should You Buy Sapiens International Corporation N.V. (NASDAQ:SPNS)?

Jun 22
When Should You Buy Sapiens International Corporation N.V. (NASDAQ:SPNS)?

Sapiens International (NASDAQ:SPNS) Might Have The Makings Of A Multi-Bagger

Jun 09
Sapiens International (NASDAQ:SPNS) Might Have The Makings Of A Multi-Bagger

Sapiens International (NASDAQ:SPNS) Has A Rock Solid Balance Sheet

May 02
Sapiens International (NASDAQ:SPNS) Has A Rock Solid Balance Sheet

Sapiens Achieving Profitable Growth But Guides For Headwinds

May 02

Is Now The Time To Look At Buying Sapiens International Corporation N.V. (NASDAQ:SPNS)?

Mar 15
Is Now The Time To Look At Buying Sapiens International Corporation N.V. (NASDAQ:SPNS)?

Are Investors Undervaluing Sapiens International Corporation N.V. (NASDAQ:SPNS) By 30%?

Feb 28
Are Investors Undervaluing Sapiens International Corporation N.V. (NASDAQ:SPNS) By 30%?

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Sapiens International. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

NasdaqGS:SPNS Ingresos, gastos y beneficios (USD Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
31 Dec 23515627763
30 Sep 23503597663
30 Jun 23491567561
31 Mar 23482537560
31 Dec 22475537559
30 Sep 22474537557
30 Jun 22473537556
31 Mar 22469517655
31 Dec 21461477654
30 Sep 21443427451
30 Jun 21423387348
31 Mar 21402376944
31 Dec 20383346841
30 Sep 20368326440
30 Jun 20353306040
31 Mar 20339285739
31 Dec 19326265437
30 Sep 19312235335
30 Jun 19303215234
31 Mar 19295165234
31 Dec 18290145234
30 Sep 18288134635
30 Jun 18287114635
31 Mar 1828455035
31 Dec 1726905932
30 Sep 1725515629
30 Jun 1723935524
31 Mar 17223124919
31 Dec 16216194416
30 Sep 16208214314
30 Jun 16198214312
31 Mar 16191204111
31 Dec 15186204010
30 Sep 15179193810
30 Jun 15167173511
31 Mar 15162163311
31 Dec 14157143211
30 Sep 14152133111
30 Jun 14146122911
31 Mar 14140122812
31 Dec 13135122712
30 Sep 13130112512
30 Jun 13125122512

Ingresos de calidad: SPNS tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio (12.1%) de SPNS son superiores a los del año pasado (11.1%).


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: En los últimos 5 años, los beneficios de lSPNS han crecido significativamente en un 24% al año.

Acelerando crecimiento: El crecimiento de los beneficios de SPNS en el último año (18.7%) está por debajo de su media de 5 años (24% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de SPNS en el último año (18.7%) no superó al de la industria Software 22.4%.


Rentabilidad financiera

Alta ROE: La rentabilidad financiera de SPNS (14%) se considera baja.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target